0.341
price down icon11.22%   -0.0431
 
loading
Schlusskurs vom Vortag:
$0.3841
Offen:
$0.332
24-Stunden-Volumen:
5.15M
Relative Volume:
17.79
Marktkapitalisierung:
$13.94M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-52.53M
KGV:
-0.0932
EPS:
-3.66
Netto-Cashflow:
$-39.93M
1W Leistung:
-57.38%
1M Leistung:
-51.24%
6M Leistung:
-65.08%
1J Leistung:
-74.36%
1-Tages-Spanne:
Value
$0.241
$0.4148
1-Wochen-Bereich:
Value
$0.241
$0.828
52-Wochen-Spanne:
Value
$0.241
$3.10

Unity Biotechnology Inc Stock (UBX) Company Profile

Name
Firmenname
Unity Biotechnology Inc
Name
Telefon
(650) 416-1192
Name
Adresse
285 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA
Name
Mitarbeiter
16
Name
Twitter
@unitybiotech
Name
Nächster Verdiensttermin
2024-11-11
Name
Neueste SEC-Einreichungen
Name
UBX's Discussions on Twitter

Vergleichen Sie UBX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
UBX
Unity Biotechnology Inc
0.341 13.94M 0 -52.53M -39.93M -3.66
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
452.01 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
536.35 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
321.08 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
547.23 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
243.78 28.51B 3.81B -644.79M -669.77M -6.24

Unity Biotechnology Inc Stock (UBX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-05-27 Herabstufung H.C. Wainwright Buy → Neutral
2025-05-16 Herabstufung Mizuho Outperform → Neutral
2024-08-22 Eingeleitet Rodman & Renshaw Buy
2023-11-16 Hochstufung Wedbush Neutral → Outperform
2022-01-04 Hochstufung ROTH Capital Neutral → Buy
2021-11-10 Hochstufung Mizuho Neutral → Buy
2021-06-28 Hochstufung Citigroup Sell → Buy
2021-06-07 Eingeleitet H.C. Wainwright Buy
2021-02-16 Herabstufung Citigroup Neutral → Sell
2020-08-18 Herabstufung Citigroup Buy → Neutral
2020-08-18 Herabstufung Mizuho Buy → Neutral
2020-08-18 Herabstufung Morgan Stanley Overweight → Equal-Weight
2020-08-17 Herabstufung ROTH Capital Buy → Neutral
2020-07-28 Eingeleitet ROTH Capital Buy
2019-12-12 Eingeleitet Cantor Fitzgerald Overweight
2019-03-07 Eingeleitet Cantor Fitzgerald Overweight
2018-09-07 Eingeleitet Mizuho Buy
2018-05-29 Eingeleitet Citigroup Buy
2018-05-29 Eingeleitet Goldman Neutral
2018-05-29 Eingeleitet Morgan Stanley Overweight
Alle ansehen

Unity Biotechnology Inc Aktie (UBX) Neueste Nachrichten

pulisher
Jun 14, 2025

Biotech company once valued at $700 million slashes entire workforce - MSN

Jun 14, 2025
pulisher
Jun 12, 2025

Fierce Biotech Layoff Tracker 2025: ADC Tx lets go of 30% of workers; Vertex sheds 125 staffers - Fierce Biotech

Jun 12, 2025
pulisher
May 30, 2025

HC Wainwright Issues Optimistic Forecast for UBX Earnings - Defense World

May 30, 2025
pulisher
May 29, 2025

Unity Biotechnology stock hits 52-week low at $0.66 - Investing.com

May 29, 2025
pulisher
May 29, 2025

Unity Biotechnology stock hits 52-week low at $0.66 By Investing.com - Investing.com India

May 29, 2025
pulisher
May 28, 2025

HC Wainwright & Co. Downgrades Unity Biotechnology (LSE:0YC0) - Nasdaq

May 28, 2025
pulisher
May 28, 2025

Unity Biotechnology (NASDAQ:UBX) Receives Neutral Rating from HC Wainwright - Defense World

May 28, 2025
pulisher
May 27, 2025

Unity Biotech stock rating downgraded at H.C. Wainwright By Investing.com - Investing.com South Africa

May 27, 2025
pulisher
May 27, 2025

This United States Steel Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Tuesday - Benzinga

May 27, 2025
pulisher
May 27, 2025

Unity Biotechnology (UBX) Downgraded Amid Strategic Shifts | UBX Stock News - GuruFocus

May 27, 2025
pulisher
May 27, 2025

HC Wainwright Downgrades Unity Biotechnology to Neutral From Buy, Adjusts Price Target to $2 From $4 - marketscreener.com

May 27, 2025
pulisher
May 27, 2025

Unity Biotechnology (UBX) Downgrade: HC Wainwright & Co. Cuts Pr - GuruFocus

May 27, 2025
pulisher
May 27, 2025

Unity Biotech stock rating downgraded at H.C. Wainwright - Investing.com

May 27, 2025
pulisher
May 27, 2025

Unity Biotechnology (UBX) Downgrade: HC Wainwright & Co. Cuts Price Target | UBX Stock News - GuruFocus

May 27, 2025
pulisher
May 21, 2025

Jeff Bezos-backed, lifespan-focused Altos Labs buys small biotech with Stanford rootsSan Francisco Business Times - The Business Journals

May 21, 2025
pulisher
May 18, 2025

Unity Biotechnology (NASDAQ:UBX) Rating Lowered to “Neutral” at Mizuho - Defense World

May 18, 2025
pulisher
May 17, 2025

Mizuho cuts Unity Biotech stock rating, slashes price target to $1 - Investing.com Nigeria

May 17, 2025
pulisher
May 16, 2025

Mizuho Downgrades Unity Biotechnology to Neutral From Outperform After Diabetic Edema Treatment Misses Primary Endpoint, Cuts Price Target to $1 From $6 - marketscreener.com

May 16, 2025
pulisher
May 16, 2025

Unity Biotechnology (UBX) Downgraded Amid Trials and Strategic N - GuruFocus

May 16, 2025
pulisher
May 11, 2025

Unity Biotechnology (UBX) to Release Earnings on Tuesday - Defense World

May 11, 2025
pulisher
May 10, 2025

Bay Area biotech company Unity, once worth $700M, lays off entire remaining workforce - MSN

May 10, 2025
pulisher
May 09, 2025

'It's a mess out there': More biotech layoffs mean stiff competition for jobs at emerging companies - The Business Journals

May 09, 2025
pulisher
May 08, 2025

Renaissance Technologies LLC Sells 16,759 Shares of Unity Biotechnology, Inc. (NASDAQ:UBX) - Defense World

May 08, 2025
pulisher
May 07, 2025

Another Bay Area biotech company announces layoffs - MSN

May 07, 2025
pulisher
May 06, 2025

Bluebird pleads for deal support; Unity, Mersana lay off staff - BioPharma Dive

May 06, 2025
pulisher
May 05, 2025

Bay Area biotech company lays off every single worker, including CEO - SFGATE

May 05, 2025
pulisher
May 05, 2025

Finance Watch: Unity Lays Off All Employees As It Evaluates Alternatives - insights.citeline.com

May 05, 2025
pulisher
May 05, 2025

UNITY Biotechnology (UBX) Reports Promising 36-Week Results from ASPIRE Trial | UBX Stock News - GuruFocus

May 05, 2025
pulisher
May 05, 2025

Unity Biotechnology Explores Strategic Alternatives Post-ASPIRE Study - TipRanks

May 05, 2025
pulisher
May 05, 2025

UNITY Biotechnology Estimates $3.7 Million Expenses For Reduction In Force - marketscreener.com

May 05, 2025
pulisher
May 05, 2025

UNITY Biotechnology Announces Complete 36-Week Results from the ASPIRE Phase 2b Study of UBX1325 in Diabetic Macular Edema and Provides Corporate Updates - The Manila Times

May 05, 2025
pulisher
May 05, 2025

UNITY Biotechnology Announces Complete 36-Week Results from - GlobeNewswire

May 05, 2025
pulisher
May 05, 2025

UNITY Biotechnology Announces Complete 36-Week Results from the ASPIRE Phase 2b Study of - Bluefield Daily Telegraph

May 05, 2025
pulisher
May 05, 2025

UNITY's New DME Treatment Rivals Aflibercept in Phase 2b Trial, Company Explores Strategic Options - Stock Titan

May 05, 2025
pulisher
May 01, 2025

UNITY Biotechnology to Present 36-Week Data from ASPIRE Phase 2B Study at ARVO 2025 Annual Meeting - Nasdaq

May 01, 2025
pulisher
May 01, 2025

UNITY Biotechnology to Present at the ARVO 2025 Annual Meeting - The Manila Times

May 01, 2025
pulisher
Apr 29, 2025

UNITY Biotechnology tanks after failing to meet goal in eye disorder treatment trial - MSN

Apr 29, 2025
pulisher
Apr 28, 2025

Chardan Capital Brokers Decrease Earnings Estimates for UBX - Defense World

Apr 28, 2025
pulisher
Apr 26, 2025

Form 8-KCurrent report - ADVFN

Apr 26, 2025
pulisher
Apr 26, 2025

HC Wainwright Issues Positive Outlook for UBX Earnings - Defense World

Apr 26, 2025
pulisher
Apr 25, 2025

HC Wainwright Reiterates “Buy” Rating for Unity Biotechnology (NASDAQ:UBX) - Defense World

Apr 25, 2025
pulisher
Apr 25, 2025

Chardan Capital Reaffirms “Buy” Rating for Unity Biotechnology (NASDAQ:UBX) - Defense World

Apr 25, 2025
pulisher
Apr 24, 2025

Unity Biotechnology Reports Q1 2025 Financials and Study Updates - TipRanks

Apr 24, 2025
pulisher
Apr 23, 2025

H.C. Wainwright maintains $4 target on Unity Biotech stock - Investing.com Australia

Apr 23, 2025
pulisher
Apr 23, 2025

Unity Biotechnology (UBX) Reports $16.9M in Cash, Prepares for F - GuruFocus

Apr 23, 2025

Finanzdaten der Unity Biotechnology Inc-Aktie (UBX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$20.71
price up icon 0.27%
$35.77
price down icon 0.53%
$21.15
price down icon 0.56%
$97.46
price down icon 3.19%
$107.69
price up icon 1.16%
biotechnology ONC
$243.26
price up icon 0.54%
Kapitalisierung:     |  Volumen (24h):